What does Panacos Pharmaceuticals, Inc. do?

Panacos Pharmaceuticals, Inc. (PANC) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is PANC's market cap?

Panacos Pharmaceuticals, Inc. (PANC) has a market capitalization of approximately $5,367, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does PANC pay a dividend?

No — Panacos Pharmaceuticals, Inc. (PANC) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Panacos Pharmaceuticals, Inc. (PANC) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

PANC

Panacos Pharmaceuticals, Inc.

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$5.37K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−90.00%CAGR −36.96%

Select date range

FromTo

Mar 14, 2005Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

PANC does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMar 5

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$99.00K

Net Income−$35.76M

Net Margin−36,116.2%

Operating Cash Flow−$31.15M

Capital Expenditures$96.00K

Free Cash Flow−$31.24M

Return on Equity−678.2%

Return on Invested Capital0.0%

Net Cash$8.68M

Analyst Estimates

PRO

Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.

Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for PANC and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how PANC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PANC and 80,000+ other tickers.

About Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs…

CEO: John R. Barr
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 41
Website: www.panacos.com

Peers

Peers Tab

ARNI

Arno Therapeutics, Inc.

Better Therapeutics, Inc.

Cap

$5.5K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About PANC

What does Panacos Pharmaceuticals, Inc. do?: Panacos Pharmaceuticals, Inc. (PANC) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is PANC's market cap?: Panacos Pharmaceuticals, Inc. (PANC) has a market capitalization of approximately $5,367, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does PANC pay a dividend?: No — Panacos Pharmaceuticals, Inc. (PANC) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is PANC profitable?: Panacos Pharmaceuticals, Inc. (PANC) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.